Yüklüyor......
In Vivo Assessment of SMT19969 in a Hamster Model of Clostridium difficile Infection
SMT19969 [2,2′-bis(4-pyridyl)3H,3′-H 5,5-bibenzimidazole] is a novel narrow-spectrum nonabsorbable antibiotic currently in development for the treatment of Clostridium difficile infection. The comparative activities of SMT19969 and vancomycin against nonepidemic and epidemic strains of C. difficile...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187990/ https://ncbi.nlm.nih.gov/pubmed/25022586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02903-14 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|